Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2002 | 03-2001 | 03-2000 | 03-1999 | 03-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 10,020 | 5,530 | 2,300 | 1,410 |
| Depreciation Amortization | N/A | 5,880 | 4,410 | 4,070 | 3,340 |
| Other Working Capital | N/A | -10,810 | -6,700 | -3,900 | -1,580 |
| Other Operating Activity | 0 | 1,100 | 550 | 270 | -230 |
| Operating Cash Flow | $N/A | $6,190 | $3,790 | $2,740 | $2,940 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -12,100 | -8,190 | -5,810 | -8,890 |
| Other Investing Activity | 0 | -1,510 | -670 | -110 | -100 |
| Investing Cash Flow | $N/A | $-13,610 | $-8,860 | $-5,920 | $-8,990 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 11,690 | 6,940 | 3,500 | 6,290 |
| Financing Cash Flow | $N/A | $11,690 | $6,940 | $3,500 | $6,290 |
| Exchange Rate Effect | N/A | -20 | 20 | -20 | -60 |
| Beginning Cash Position | N/A | 3,000 | 1,100 | 800 | 620 |
| End Cash Position | N/A | 7,240 | 3,000 | 1,100 | 800 |
| Net Cash Flow | $N/A | $4,240 | $1,890 | $300 | $180 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 6,190 | 3,790 | 2,740 | 2,940 |
| Free Cash Flow | 0 | 6,190 | 3,790 | 2,740 | 2,940 |